Differentiation of B cells into plasma cells requires X-box binding protein–1 (XBP-1). In the absence of XBP-1, B cells develop normally, but very little immunoglobulin is secreted. XBP-1 controls the expression of a large set of genes whose products participate in expansion of the endoplasmic reticulum (ER) and in protein trafficking. We define a new role for XBP-1 in exerting selective translational control over high and sustained levels of immunoglobulin M (IgM) synthesis. XBP-1−/− and XBP-1+/+ primary B cells synthesize IgM at comparable levels at the onset of stimulation with lipopolysaccharide or CpG. However, later there is a profound depression in synthesis of IgM in XBP-1−/− B cells, notwithstanding similar levels of μmRNA. In marked contrast, lack of XBP-1 does not affect synthesis and trafficking of other glycoproteins, or of immunoglobulin light chains. Contrary to expectation, degradation of proteins from the ER, using TCRα or US11-mediated degradation of class I major histocompatibility complex molecules as substrates, is normal in XBP-1−/− B cells. Furthermore, degradation of membrane μ was unaffected by enforced expression of XBP-1. We conclude that in primary B cells, the XBP-1 pathway promotes synthesis and secretion of IgM, but does not seem to be involved in the degradation of ER proteins, including that of μ chains themselves.
Skip Nav Destination
Article navigation
15 August 2005
Article Contents
Article|
August 15 2005
XBP-1 specifically promotes IgM synthesis and secretion, but is dispensable for degradation of glycoproteins in primary B cells
Boaz Tirosh,
Boaz Tirosh
1Department of Pathology, Harvard Medical School
Search for other works by this author on:
Neal N. Iwakoshi,
Neal N. Iwakoshi
2Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115
Search for other works by this author on:
Laurie H. Glimcher,
Laurie H. Glimcher
2Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115
Search for other works by this author on:
Hidde L. Ploegh
Hidde L. Ploegh
1Department of Pathology, Harvard Medical School
Search for other works by this author on:
Boaz Tirosh
1Department of Pathology, Harvard Medical School
Neal N. Iwakoshi
2Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115
Laurie H. Glimcher
2Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA 02115
Hidde L. Ploegh
1Department of Pathology, Harvard Medical School
CORRESPONDENCE Hidde L. Ploegh: [email protected]
Abbreviations used: μm, membrane μ; μs, secretory μ; ATF, activating transcription factor; EDEM, ER degradation enhancing α-mannosidase-like protein; HC, class I MHC heavy chain; IRES, internal ribosome entry site; PERK, PKR-like endoplasmic reticulum eIF2α kinase; SRP, signal recognition particle; UPR, unfolded protein response; XBP-1, X-box binding protein 1; XBP-1s, spliced XBP-1.
Received:
March 18 2005
Accepted:
July 06 2005
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2005
J Exp Med (2005) 202 (4): 505–516.
Article history
Received:
March 18 2005
Accepted:
July 06 2005
Citation
Boaz Tirosh, Neal N. Iwakoshi, Laurie H. Glimcher, Hidde L. Ploegh; XBP-1 specifically promotes IgM synthesis and secretion, but is dispensable for degradation of glycoproteins in primary B cells . J Exp Med 15 August 2005; 202 (4): 505–516. doi: https://doi.org/10.1084/jem.20050575
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement